Kim J - Search Results

1

Impact of next-generation hormonal agents on treatment patterns among patients with metastatic hormone-sensitive prostate cancer: a real-world study from the United States, five European countries and Japan.

Leith A, Ribbands A, Kim J, Clayton E, Gillespie-Akar L, Yang L, Ghate SR. Leith A, et al. Among authors: kim j. BMC Urol. 2022 Mar 11;22(1):33. doi: 10.1186/s12894-022-00979-9. BMC Urol. 2022. PMID: 35277153 Free PMC article.

2

Real-world homologous recombination repair mutation testing in metastatic castration-resistant prostate cancer in the USA, Europe and Japan.

Leith A, Ribbands A, Kim J, Last M, Barlow S, Yang L, Ghate SR. Leith A, et al. Among authors: kim j. Future Oncol. 2022 Mar;18(8):937-951. doi: 10.2217/fon-2021-1113. Epub 2022 Jan 19. Future Oncol. 2022. PMID: 35043687

3

Beyond Frontline Therapy with Abiraterone and Enzalutamide in Metastatic Castration-Resistant Prostate Cancer: A Real-World US Study.

Shore ND, Ionescu-Ittu R, Laliberté F, Yang L, Lejeune D, Yu L, Duh MS, Mahendran M, Kim J, Ghate SR. Shore ND, et al. Among authors: kim j. Clin Genitourin Cancer. 2021 Dec;19(6):480-490. doi: 10.1016/j.clgc.2021.07.009. Epub 2021 Jul 10. Clin Genitourin Cancer. 2021. PMID: 34373223 Free article.

4

Real-World Treatment Patterns in Metastatic Castration-Resistant Prostate Cancer Across Europe (France, Germany, Italy, Spain, and the United Kingdom) and Japan.

Leith A, Kim J, Ribbands A, Clayton E, Yang L, Ghate SR. Leith A, et al. Among authors: kim j. Adv Ther. 2022 May;39(5):2236-2255. doi: 10.1007/s12325-022-02073-w. Epub 2022 Mar 22. Adv Ther. 2022. PMID: 35316501 Free PMC article.

5

Systematic Literature Review of the Epidemiology of Advanced Prostate Cancer and Associated Homologous Recombination Repair Gene Alterations.

Shore N, Oliver L, Shui I, Gayle A, Wong OY, Kim J, Payne S, Amin S, Ghate S. Shore N, et al. Among authors: kim j. J Urol. 2021 Apr;205(4):977-986. doi: 10.1097/JU.0000000000001570. Epub 2020 Dec 17. J Urol. 2021. PMID: 33332152

6

The Association of Periprostatic Fat and Grade Group Progression in Men with Localized Prostate Cancer on Active Surveillance.

Gregg JR, Surasi DS, Childs A, Moll N, Ward JF, Kim J, Daniel CR, Logothetis C, Bathala T, Davis JW. Gregg JR, et al. Among authors: kim j. J Urol. 2021 Jan;205(1):122-128. doi: 10.1097/JU.0000000000001321. Epub 2020 Jul 27. J Urol. 2021. PMID: 32718204 Free PMC article.

7

Determining Clinically Based Factors Associated With Reclassification in the Pre-MRI Era using a Large Prospective Active Surveillance Cohort.

Gregg JR, Davis JW, Reichard C, Wang X, Achim M, Chapin BF, Pisters L, Pettaway C, Ward JF, Choi S, Nguyen QN, Kuban D, Babaian R, Troncoso P, Madsen LT, Logothetis C, Kim J. Gregg JR, et al. Among authors: kim j. Urology. 2020 Apr;138:91-97. doi: 10.1016/j.urology.2019.11.041. Epub 2019 Dec 30. Urology. 2020. PMID: 31899230 Free PMC article.

8

KEYNOTE-641: a Phase III study of pembrolizumab plus enzalutamide for metastatic castration-resistant prostate cancer.

Graff JN, Liang LW, Kim J, Stenzl A. Graff JN, et al. Among authors: kim j. Future Oncol. 2021 Aug;17(23):3017-3026. doi: 10.2217/fon-2020-1008. Epub 2021 May 28. Future Oncol. 2021. PMID: 34044584

9

Factors Associated with Time to Conversion from Active Surveillance to Treatment for Prostate Cancer in a Multi-Institutional Cohort.

Cooley LF, Emeka AA, Meyers TJ, Cooper PR, Lin DW, Finelli A, Eastham JA, Logothetis CJ, Marks LS, Vesprini D, Goldenberg SL, Higano CS, Pavlovich CP, Chan JM, Morgan TM, Klein EA, Barocas DA, Loeb S, Helfand BT, Scholtens DM, Witte JS, Catalona WJ; Collaborators. Cooley LF, et al. J Urol. 2021 Nov;206(5):1147-1156. doi: 10.1097/JU.0000000000001937. Epub 2021 Sep 10. J Urol. 2021. PMID: 34503355 Free PMC article.

10

Coffee Intake, Caffeine Metabolism Genotype, and Survival Among Men with Prostate Cancer.

Gregg JR, Kim J, Logothetis C, Hanash S, Zhang X, Manyam G, Muir K; UKGPCS Collaborative Group; Giles GG, Stanford JL, Berndt SI, Kogevinas M, Brenner H, Eeles RA; PRACTICAL Consortium; Wei P, Daniel CR. Gregg JR, et al. Among authors: kim j. Eur Urol Oncol. 2023 Jun;6(3):282-288. doi: 10.1016/j.euo.2022.07.008. Epub 2022 Aug 20. Eur Urol Oncol. 2023. PMID: 35995710 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

130,277 results

Search Page